Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: Correlation with histopathological parameters, hormone receptors, and oncoproteins

Journal of Pathology

Volumn 193, Issue 2, 2001, Pages 181-189

  Dandachi, N ^a   Hauser Kronberger, C ^a,e   More E ^a,c   Wiesener, B ^a,b   Hacker, G W ^b   Dietze, O ^d   Wirl, G ^a  

^a Institute of Pathological Anatomy   (Austria)

^b UNIVERSITY OF SALZBURG   (Austria)

^c First Dept of Internal Medicine   (Austria)

^d ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^e St Johanns Spital   (Austria)

Author keywords

C erbB 2; Clinical parameters; Epithelial mesenchymal transition; Hormone receptors; Human breast carcinoma; Tenascin C; Vimentin

Indexed keywords

ESTROGEN RECEPTOR; HORMONE RECEPTOR; ONCOPROTEIN; TENASCIN; VIMENTIN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MYOEPITHELIUM CELL; ONCOGENE C ERB; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REGULATOR GENE; TUMOR GROWTH; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DOWN-REGULATION; FEMALE; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS V-ERBB; PHENOTYPE; RECEPTORS, ESTROGEN; TENASCIN; TUMOR CELLS, CULTURED; VIMENTIN;

EID: 0035147248     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH752>3.0.CO;2-V     Document Type: Article

References (40)

1. Tenascin-C, tenascin-R, and tenascin-X: A family of talented proteins in search of their functions
2. The complexity in regulating the expression of tenascins
3. Tenascins, a growing family of extra-cellular matrix proteins
4. Tenascin and other adhesion-modulating proteins in cancer
5. Tenascin in connective tissue development and pathogenesis
6. Tenascin splice variants: Differential binding to fibronectin and distinct distribution in cell cultures and tissues
7. Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II
8. Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues
9. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast
10. Epithelial cells are an important source of tenascin in normal and malignant human breast tissue
11. Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance
12. Tenascin in breast cancer development-is epithelial tenascin a marker for poor prognosis?
13. Biologic and oncologic implications of tenascin-C/ hexabrachion proteins
14. Tenascin staining positivity and the survival of patients with invasive breast carcinoma
15. Tenascin-C expression in invasion border of early breast cancer: A predictor of local and distant recurrence
16. Mammary epithelial cell differentiation in vitro is regulated by an interplay of EGF action and tenascin-C downregulation
17. Vimentin: An evaluation of its role as a tumor marker
18. Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast
19. Differentiation state and invasiveness of human breast cancer cell lines
20. p53 protein and vimentin in invasive ductal NOS breast carcinoma-relationship with survival and sites of metastases
21. The relationship of cytoplasmic intermediate filaments and membrane antigens with hormone receptors, nuclear staining intensity, and mode of stromal invasion in human breast cancer
22. Loss of epithelial markers and acquisition of vimentin expression in adriamycin-and vinblastine-resistant human breast cancer cell lines
23. Experimental coexpression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior
24. Histologic grading and prognosis in breast cancer
25. cdc2 in invasive breast cancer: Relationship to DNA content, Ki67 index and c-erbB-2 expression
26. HBL100, a cell line established from human breast milk
27. Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with recombinant retrovirus
28. Actin cytoskeleton polymerization in Dbl-transformed NIH3T3 fibroblasts is dependent on cell adhesion to specific extracellular matrix proteins
29. Two syngeneic cell lines from human breast tissue: The aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines
30. Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues
31. Multiple integrins mediate cell attachment to cytotactin/tenascin
32. Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction
33. Expression of vimentin in surgically resected adenocarcinomas and large cell carcinomas of lung
34. Intermediate filaments in endometrial and endocervical carcinomas
35. Vimentin expression in cervical carcinomas: Association with invasive and migratory potential
36. Rearrangements of desmosomal and cytosketal proteins during the transition from epithelial to fibroblastoid organization in cultured rat bladder carcinoma cells
37. Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in matrigel-based in vitro assas
38. Vimentin is preferentially expressed in high grade ductal and medullary, but not in lobular breast carcinomas
39. Acquisition of tumorigenic potential in the human myoepithelial HBL100 cell line is associated with decreased expression of HLA class I, class II and integrin β3 and increased expression of c-myc
40. TGF-β signaling is necessary for carcinoma cell invasiveness and metastasis